Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Hopkins, A.M. (Ashley M.)"'
Autor:
Li, L.X. (Lee X.), Cappuzzo, F. (Federico), Matos, I. (Ignacio), Socinski, M.A. (Mark A.), Hopkins, A.M. (Ashley M.), Sorich, M.J. (Michael J.)
Background Monotherapy immune checkpoint inhibitor (ICI) used in second- or later-line settings has been reported to induce hyperprogression. This study evaluated hyperprogression risk with ICI (atezolizumab) in the first-, second-, or later-line tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1111::e8d8ca896d7412e246443dbc4e176c47
https://hdl.handle.net/10171/66059
https://hdl.handle.net/10171/66059
